GPGI (GPGI) Q3 2026 Earnings Call Transcript

GPGI reported Q3 2026 earnings with sales up 5% YoY to $509.6M and EBITDA up 7% to $146.3M. The company expects low single-digit revenue growth and high single-digit EBITDA growth in Q4. Full-year 2026 guidance was adjusted, with revenue expected to meet prior forecasts but EBITDA and free cash flow lowered due to Husky's delayed cost actions and mix issues. GPGI aims for long-term growth with mid- to high single-digit annual organic growth and double-digit EBITDA growth.

Original reporting
Published Nov 5, 2026, 6:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 7:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
GPGI (GPGI) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$GPGIBearishHigh
01

Why it matters

The earnings release provides fresh numbers and revised outlook, which can shift valuation models and trigger trading activity.

02

Market read

The guidance downgrade is the primary catalyst for potential price movement in GPGI shares.

03

What to watch

Strong performance in the CompoSecure segment and a 5% YoY sales increase may offset the EBITDA downgrade.

Relevance 8/10Novelty 8/10Timing: after-hours Q3 earnings release

Background

GPGI (Global Partners GP) reported Q3 2026 results and updated FY guidance, highlighting mixed performance across its Husky and CompoSecure businesses.

Company-level read

Ticker impact

$GPGIBearishHigh confidence
Context

Q3 2026 earnings call disclosed pro forma net sales of $509.6M and adjusted EBITDA of $146.3M, plus lowered FY2026 EBITDA guidance.

Expected impact

likely downward pressure as market prices in lower EBITDA expectations

Evidence & confidence

The company reduced its FY2026 adjusted EBITDA and free cash flow outlook, which is new material information for investors.

Market effects

May weigh on other specialty industrial equipment peers as guidance softness signals broader market pressure.

Primarily affects US-listed industrials and investors tracking mid-cap earnings.

Limited to investors with exposure to GPGI and similar niche manufacturers.

Counterpoint

If the market overreacts to the modest guidance cut, the stock could be a short‑term buying opportunity.

Key entities

  • GPGI

    Publicly listed industrial equipment provider (NASDAQ: GPGI).

Related articles

$GPGIMed

GPGI 3Q 2026: Revenue $0, EPS $0.26 — 10-Q Summary

GPGI reported 3Q 2026 revenue of $0 but net income of $76M, up 143.5% YoY, driven by equity-method investment earnings. GPGI Holdings sales rose 321.5% YoY to $509.6M, with Husky and CompoSecure contributing to growth. Adjusted EBITDA for CompoSecure and Husky combined was $150.0M, up from $49.8M YoY.

$GPGILow

GPGI Third Quarter 2026 Earnings Presentation November 5, 2026 TM

GPGI, Inc. (GPGI) filed an SEC Form 8-K — Results of Operations and Financial Condition. GPGI Third Quarter 2026 Earnings Presentation November 5, 2026 TM Disclaimer 2 Caution Concerning Forward-Looking Statements: This presentation, and other statements that GPGI, Inc. (“GPGI,” “we,” “us” or the “Company”) may make in connection therewith, contains forward-looking s

$GPGIMedAI 8/10

GPGI (GPGI) Q2 2026 Earnings Call Transcript

GPGI, Inc. (GPGI) reported Q2 2026 results on an earnings call. Pro forma adjusted net sales were $473.2 million, down 4%, and pro forma adjusted EBITDA was $113.9 million, down 13%, with margin at 24.1%. GAAP net income was $50.3 million. FY2026 guidance: revenue $1.95B-$2.1B, adjusted EBITDA $550M-$610M, and free cash flow $275M-$325M.

$GPGIMed

1 News Release GPGI Reports Second Quarter 2026 Results

GPGI, Inc. (GPGI) filed an SEC Form 8-K — Results of Operations and Financial Condition. 1 News Release GPGI Reports Second Quarter 2026 Results ▪ CompoSecure delivers record ROS-enabled results ▪ Husky performance in line with expectations ▪ ROS deployment accelerating at both companies ▪ Progress across the platform – reiterating full year 2026 guidance Second Quar

$AAOIMedAI 8/10

Applied Optoelectronics Says AI Demand Will Outrun Its Capacity Through 2027

Applied Optoelectronics (AAOI) reported Q3 revenue of $269.9M, up 128% YoY, with AI demand driving growth. CFO Stefan Murry stated demand will outpace capacity through 2027. The company signed a multi-year deal with a hyperscaler customer, expecting $1B-$1.5B in revenue. Q4 guidance of $385M-$420M trails consensus. Analysts cut price targets post-earnings. Stock fell 20.89% pre-earnings, then rose 6.87% post-earnings.